肿瘤细胞治疗研究
ALL SOURCES
Myeloid-derived suppressor cells in anaplastic thyroid carcinoma: insights from prospective immune profiling and implications for targeted immunothera
ATC微环境中富含免疫抑制性MDSC。这些发现支持以MDSC为重点的免疫调节作为ATC中有前景的辅助治疗。
Natural Killer Cell and Extracellular Vesicle-Based Immunotherapy in Thyroid Cancer: Advances, Challenges, and Future Perspectives.
甲状腺癌是最常见的内分泌肿瘤，由一组异质性的组织学亚型组成，从惰性的甲状腺乳头状癌（PTC）到快速进展且致命的甲状腺未分化癌（ATC）。
Tumor-Infiltrating Lymphocytes Assessed Using the International TILs Working Group System Are Not Prognostic in Medullary Thyroid Cancer.
结果：我们确定了71例原发性MTC肿瘤患者，这些患者在1995年至2016年间在澳大利亚悉尼皇家北岸医院接受了手术治疗。
Unravelling the Reasons Behind Limited Response to Anti-PD Therapy in ATC: A Comprehensive Evaluation of Tumor-Infiltrating Immune Cells and Checkpoin
基于PD-L1表达状态抑制免疫检查点（ICP）PD-1已彻底改变了多种癌症的治疗，但其在未分化甲状腺癌（ATC）中的疗效仍然有限。
共 4 条
MEMBER ACCOUNT
登录成功会直接打开下一页。
